ABVC BioPharma, Inc. Short-term Debt, Average Outstanding Amount
ABVC BioPharma, Inc. (ABVC) reported Short-term Debt, Average Outstanding Amount of $500.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-15.
Discontinued › Notes › Debt
us-gaap:ShorttermDebtAverageOutstandingAmount · last filed 2024-05-17
- ABVC BioPharma, Inc. short-term debt, average outstanding amount for the quarter ending 2023-09-30 was $0.00.
- ABVC BioPharma, Inc. short-term debt, average outstanding amount for the quarter ending 2023-06-30 was $0.00.
- ABVC BioPharma, Inc. short-term debt, average outstanding amount for the quarter ending 2023-03-31 was $500.00K.
- ABVC BioPharma, Inc. short-term debt, average outstanding amount for the quarter ending 2021-12-31 was $32.82K.
- ABVC BioPharma, Inc. short-term debt, average outstanding amount for fiscal 2021 was $33.52K.
- ABVC BioPharma, Inc. short-term debt, average outstanding amount for fiscal 2017 was $950.00K.
- ABVC BioPharma, Inc. short-term debt, average outstanding amount for fiscal 2017 was $950.00K.
| Period end | Short-term Debt, Average Outstanding Amount 3 month | Short-term Debt, Average Outstanding Amount 6 month | Short-term Debt, Average Outstanding Amount 9 month | Short-term Debt, Average Outstanding Amount 12 month | Short-term Debt, Average Outstanding Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15 | $0.00 derived: sum of 2 quarters · filed 2023-11-15 | $500.00K 10-Q · filed 2023-11-15 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $500.00K 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $500.00K 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $1.00M 10-Q · filed 2024-05-17 | $500.00K 10-K · filed 2023-03-31 | |||
| 2021-12-31 | $32.82K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $31.60K derived: sum of 2 quarters · filed 2023-03-31 | $31.43K derived: sum of 3 quarters · filed 2023-03-31 | $33.52K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$1.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$1.39K derived: sum of 2 quarters · filed 2021-11-15 | $703.00 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$175.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.92K 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $2.09K 10-Q · filed 2021-05-10 | ||||
| 2020-12-31 | $0.00 10-Q · filed 2021-11-15 | ||||
| 2019-03-31 | $233.00K 10-Q · filed 2019-05-28 | $132.98K derived: sum of 2 quarters · filed 2019-05-28 | $132.98K derived: sum of 3 quarters · filed 2019-05-28 | -$24.02K derived: sum of 4 quarters · filed 2019-05-28 | |
| 2018-12-31 | -$100.02K derived: 10-Q 12 month − 10-Q 9 month · filed 2019-05-28 | -$100.02K derived: sum of 2 quarters · filed 2019-05-28 | -$257.02K derived: sum of 3 quarters · filed 2019-05-28 | $692.98K 10-Q · filed 2019-05-28 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$157.00K derived: sum of 2 quarters · filed 2018-11-14 | $793.00K 10-Q · filed 2018-11-14 | $1.74M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2018-06-30 | -$157.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-20 | $793.00K 10-Q · filed 2018-08-20 | $1.74M derived: sum of 3 quarters · filed 2018-08-20 | ||
| 2018-03-31 | $950.00K 10-Q · filed 2018-05-15 | $1.90M derived: sum of 2 quarters · filed 2018-05-15 | |||
| 2017-12-31 | $950.00K 10-Q · filed 2018-05-15 | $950.00K 10-K · filed 2019-04-15 | |||
| 2017-09-30 | $950.00K 10-KT · filed 2018-04-13 |